Hyphens Pharma International Ltd
SGX:1J5
Hyphens Pharma International Ltd
Cost of Revenue
Hyphens Pharma International Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Cost of Revenue
-S$125.9m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Cost of Revenue
-S$110.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Cost of Revenue
-S$5.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Hyphens Pharma International Ltd
Glance View
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
See Also
What is Hyphens Pharma International Ltd's Cost of Revenue?
Cost of Revenue
-125.9m
SGD
Based on the financial report for Dec 31, 2024, Hyphens Pharma International Ltd's Cost of Revenue amounts to -125.9m SGD.
What is Hyphens Pharma International Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-10%
Over the last year, the Cost of Revenue growth was -16%. The average annual Cost of Revenue growth rates for Hyphens Pharma International Ltd have been -17% over the past three years , -10% over the past five years .
You don't have any saved screeners yet